Research Results

Beta Version

Use the search bar below to find studies, or apply one or more filters to narrow your results. See our list of keywords to guide your search.

Search by keyword

Try these: air pollutionalcoholbisphenolshormonespersonal care productspesticidesplastic

Filter by Risk Factors
Filter by Protective Factors
Filter by Exposure Sources
Filter by Chemical Classes

Sort By

  • Relevance
  • Title (A to Z)
  • Title (Z to A)
  • Publication Year (Ascending)
  • Publication Year (Descending)
  • Authors (A to Z)
  • Authors (Z to A)

US EPA’s regulatory pesticide evaluations need clearer guidelines for considering mammary gland tumors and other mammary gland effects.

Cardona et al,

2020

Mol Cell Endocrinol

A review of EPA pesticide registration documents found that 28 pesticides cause mammary tumors in animals and five alter mammary gland development, yet the agency’s risk assessments often dismiss these findings or don’t evaluate their implications for breast cancer risk. Many of these pesticides work through hormone-disrupting pathways that could affect breast tissue, including common chemicals like malathion, atrazine, and triclopyr. The authors argue that current testing guidelines don’t adequately assess effects on the mammary gland and call for re-evaluation of several widely-used pesticides based on stronger standards informed by breast cancer biology.

The effects of bisphenol A, benzyl butyl phthalate, and di(2-ethylhexyl) phthalate on estrogen receptor alpha in estrogen receptor-positive cells under hypoxia.

Park et al,

2019

Environ Pollut

This study investigated how three endocrine-disrupting chemicals (BPA, BBP, and DEHP) affect estrogen receptor alpha (ERα) activity under normal and low-oxygen (hypoxic) conditions in breast and endometrial cancer cells. The researchers found that BPA and BBP activated ERα at specific concentrations, while DEHP did not, but all three chemicals enhanced ERα-mediated gene activity and decreased ERα protein levels under hypoxic conditions. BPA and BBP also affected hypoxia-related factors, decreasing hypoxia-inducible factor-1 activity while increasing VEGF (a blood vessel growth factor) secretion in breast cancer cells, whereas DEHP had different effects. The findings suggest that these endocrine disruptors can alter ERα regulation under low-oxygen conditions, which may influence disease processes since hypoxia is common in tumors and other pathological states.

Parabens and their effects on the endocrine system.

Nowak et al,

2018

Mol Cell Endocrinol

A review examining parabens—one of the most widely used preservatives worldwide in foods, cosmetics, and pharmaceuticals—found that these easily absorbed chemicals are classified as endocrine-disrupting chemicals (EDCs) that can disrupt hormonal homeostasis and cause multidirectional health implications affecting body fitness and function. The review summarizes current literature on paraben properties, occurrence, metabolism, and particularly their influence on the human endocrine system, emphasizing the importance of assessing their safety given their ubiquitous use and absorption. With parabens now recognized as EDCs capable of disrupting endocrine function, the authors highlight concerns about widespread population exposure through everyday consumer products and the need for precise assessment of their health impacts on human physiology.

Breast cancer is associated with methylation and expression of the a disintegrin and metalloproteinase domain 33 (ADAM33) gene affected by endocrine‑disrupting chemicals.

Yang et al,

2018

Oncol Rep

This study investigated whether exposure to bisphenol A (BPA) and phthalate metabolites affects breast cancer risk through epigenetic changes in the ADAM33 gene, which plays a role in cancer progression. The researchers conducted a case-control study with 44 breast cancer patients and 22 controls, analyzing ADAM33 gene methylation patterns in blood samples and measuring urinary concentrations of endocrine-disrupting chemicals. They found that certain phthalate metabolites (MEHHP, MECPP, MEOHP) were positively associated with increased methylation of the ADAM33 gene, which was linked to higher gene expression levels. Surprisingly, the study suggests these phthalate metabolites may have a protective effect against breast cancer by increasing ADAM33 methylation and expression, contrary to the typical expectation that endocrine disruptors increase cancer risk.

Implication of dietary phthalates in breast cancer. A systematic review.

Zuccarello et al,

2018

Food Chem Tox

A systematic review of 25 studies examining phthalates (plastic chemicals) and breast cancer found that while laboratory studies show certain phthalates can activate estrogen receptors and promote cancer cell growth, epidemiological studies in humans have produced mixed and inconclusive results. The main source of phthalate exposure is through diet—particularly from food and beverages in plastic packaging—but current human studies have significant limitations in how they measure exposure and account for other risk factors. The review calls for better-designed future studies that use hair samples instead of urine for more accurate long-term exposure assessment, include dietary factors and genetic markers as confounders, and investigate phthalates’ effects beyond just estrogen-driven cancers to include all breast cancer subtypes.

Environmental estrogen-like endocrine disrupting chemicals and breast cancer.

Morgan et al,

2017

Molec Cell Endocrinol

This study examines the role of environmental estrogen-like endocrine-disrupting chemicals (EEDs) in breast cancer development. EEDs are synthetic compounds that mimic estrogen, and the ones being studied in this paper include polychlorinated biphenyls (PCBs), bisphenol A (BPA), and phthalates. The results of the study show that of the EEDs tested, only one type of PCB, PCB138, had a strong association with the formation of breast cancer, where as phthalates (and it metabolites) but and BPA showed no strong correlation. Additionaly, the researchers identify that these EEDs promote the proliferation of breast cancer cells, induce epigenetic changes that may increase susceptibility to cancer, as well as alter developmental pathways during critical windows of breast development.

A review of hair product use on breast cancer risk in African American women.

Stiel et al,

2016

Cancer Med

A review examining breast cancer disparities in African American women—who now have similar incidence rates to non-Hispanic White women but significantly higher mortality—found growing evidence linking hair product use to breast cancer risk through exposure to estrogen-like chemicals and endocrine-disrupting chemicals (EDCs). The review identified three converging lines of evidence: environmental estrogen and EDC exposures increase breast cancer risk, these chemicals are present in personal care products including hair products, and certain hair products used disproportionately by African American women may contribute to elevated breast cancer risk in this population. The findings highlight an understudied environmental justice issue and call for additional research using community-collaborative approaches to better understand how culturally specific beauty practices may contribute to health disparities, representing what researchers term the potential “cost of beauty.”

Early-life Exposure to Endocrine Disrupting Chemicals and Later-life Health Outcomes: An Epigenetic Bridge?

Vaiserman et al,

2014

Aging Dis

The following review article described how exposure to EDCs during early development can lead to adverse health outcomes later in life through epigenetic mechanisms based on existing studies. The article emphasizes that exposure to EDCs during critical developmental periods such as in utero and early childhood, can have lasting effects on health since, during these periods, the body’s systems are particularly vulnerable to exposures. Additionally, the article finds a link between early-life exposure to EDCs and increased risk of various health issues later on in life, including metabolic disorders and cancers. The suspected mechanism by which these chemicals do this is thought to be mediated by epigenetic changes, which are changes to gene expression without altering the DNA. Therefore, the article emphasizes understanding how exposure during such sensitive periods in development can pose such drastic problems later on in life.

Designing Endocrine Disruption Out of the Next Generation of Chemicals.

Schug et al,

2013

Green Chemistry

Scientists have developed TiPED (Tiered Protocol for Endocrine Disruption), a voluntary five-tier testing system designed to help chemists identify hormone-disrupting properties in new chemicals during the design phase—before they enter consumer products—ranging from computer-based predictions to cell and animal studies. The protocol was created by experts in green chemistry and environmental health to broadly test whether new chemicals can mimic or block hormones or interfere with hormone signaling, which is critical for preventing endocrine disruption that can contribute to diseases like breast cancer. Testing of six known endocrine disruptors with different mechanisms of action successfully identified all of them, demonstrating the protocol’s effectiveness, though the system will continue evolving as scientific understanding advances. This tool represents an important shift toward preventing chemical hazards at the design stage rather than discovering them years later after widespread human exposure, which could significantly reduce public health risks including breast cancer.

Endocrine disruptors and asthma-associated chemicals in consumer products.

Dodson et al,

2012

Environ Health Perspect

This study analyzed 213 everyday products, including cosmetics, cleaners, and personal care items, for endocrine-disrupting chemicals (EDCs) and asthma-related compounds. Testing revealed 55 chemicals, with fragranced products and sunscreens containing the highest levels. Vinyl products were also found to contain significant amounts of bis(2-ethylhexyl) phthalate (DEHP), a known EDC. Many harmful chemicals were not listed on product labels, limiting consumer ability to avoid them. These results highlight the presence of potentially harmful chemicals in commonly used products, raising concerns about their widespread use in household and personal care items.

Endocrine-disrupting pesticides in infant formulas marketed in Brazil: Interference-free GC-MS analysis and early-life dietary exposure assessment.

Petrarca et al,

2025

Food Res Int

A study analyzing 60 infant formula products sold in Brazil detected dimethoate, an endocrine-disrupting insecticide, in five samples, with one soy-based formula exceeding the legal residue limit of 10 µg/kg established to protect infants under 1 year old. While estimated daily intakes from the contaminated formulas were within acceptable safety limits and unlikely to cause immediate health concerns, the findings are notable because infants are particularly vulnerable to endocrine-disrupting chemicals during critical developmental windows in the first months of life. The research highlights the need for continued monitoring of pesticide residues in infant formula, as exposure to endocrine disruptors during early development can have long-lasting effects on hormonal systems and potentially increase risks for diseases like breast cancer later in life.

Review of evidence: Are endocrine-disrupting chemicals in the aquatic environment impacting fish populations?

Mills et al,

2025

Sci Total Environ

A review of endocrine-disrupting compounds (EDCs) in aquatic environments examined two key questions: whether EDCs can impact fish reproductive health and survival, and whether they are actually affecting wild fish populations. Laboratory evidence strongly supports that aquatic EDCs can impair reproductive health in various fish species, but evidence that environmental EDC exposure is actually impacting reproductive success and sustainability of indigenous fish populations in their natural habitats remains limited and less convincing. The authors note that this evidence gap may reflect the critical need for reliable in situ methods to assess fish reproduction and population structure changes in EDC-exposed populations, emphasizing that linking endocrine disruption and reproductive impairment to ecologically relevant impacts on wild fish population sustainability remains an open scientific challenge with few exceptions.

Surveillance and dietary risk assessment of endocrine-disrupting pesticides in eggplant/brinjal and cauliflower in Pakistan.

Talat et al,

2023

Environ Sci Poll Res

A study of vegetables sold in Pakistan found that 80% of eggplant and 69% of cauliflower samples were contaminated with endocrine-disrupting pesticides, with 20% of eggplant exceeding EU safety limits and particularly high levels of chlorpyrifos (an androgen blocker) and cyhalothrin-lambda (a thyroid hormone inhibitor). The acute health risk from eating contaminated cauliflower exceeded safe limits by more than 200% for both men and women, meaning a single serving could deliver more than twice the acceptable daily dose of these hormone-disrupting chemicals. While estimated long-term (chronic) health risks were low for most population groups, the high acute exposure is concerning because these pesticides can interfere with hormone function and potentially increase risks for hormone-related diseases like breast cancer, especially with repeated exposures over time.

A comprehensive assessment of endocrine-disrupting chemicals in an Indian food basket: Levels, dietary intakes, and comparison with European data.

Sharma et al,

2021

Environ Pollut

A study comparing endocrine-disrupting chemical (EDC) contamination in Indian food found that while all tested foods—especially dairy and meat—contained organochlorine pesticides, PCBs, PBDEs, and dioxins, overall dietary exposure levels were comparable to or lower than those in Europe despite weaker regulations in India. Urban Delhi markets had higher contamination than peri-urban areas, with organochlorine pesticides being the primary contaminants, yet Indians’ lower meat consumption meant their total EDC exposure was similar to Europeans’ despite some European foods having higher chemical residues. The findings highlight that EDC contamination is a global food system issue driven by international trade of food and animal feed, underscoring the need for internationally harmonized standards on EDC limits in food to protect public health worldwide, as chemical exposures that increase risks for diseases like breast cancer cross borders through the global food supply.

Pharmaceuticals and endocrine disruptors in raw and cooked seafood from European market: Concentrations and human exposure levels.

Álvarez-Muñoz et al,

2018

Environ Int

A study analyzing 65 seafood samples (195 analyses including raw and cooked preparations) from 11 European countries for pharmaceuticals (PhACs) and endocrine-disrupting compounds (EDCs)—chemicals linked to reproductive system effects, metabolic disorders, breast cancer pathogenesis, and antimicrobial resistance—found that while pharmaceuticals were mostly undetectable, EDCs were quantified in the majority of samples, with cooking by steaming significantly increasing their levels 2- to 46-fold. Human exposure assessment focused on three prevalent EDCs (bisphenol A, methylparaben, and triclosan) revealed that the Spanish population had the highest exposure through seafood consumption among the 11 countries studied, though exposures remained below current toxicological reference values. These findings highlight that commercially available seafood in the European Union market contains detectable levels of endocrine-disrupting contaminants that concentrate during cooking, raising concerns about cumulative dietary exposure to these compounds through this widely consumed protein source, particularly in populations with high seafood consumption patterns.

Low dose bisphenol S or ethinyl estradiol exposures during the perinatal period alter female mouse mammary gland development.

Kolla et al,

2018

Reprod Toxicol

A developmental toxicology study exposed CD-1 mice to bisphenol S (BPS) at 2 or 200 μg/kg/day or ethinyl estradiol (EE2) at 0.01 or 1 μg/kg/day during pregnancy and lactation, then examined mammary glands of female offspring at three developmental stages (pre-puberty, puberty, and early adulthood) for growth parameters, histopathology, cell proliferation, and hormone receptor expression. The study revealed age- and dose-specific effects of BPS on mammary gland development that differed from both EE2 effects and previously reported bisphenol A (BPA) effects. These findings suggest that individual xenoestrogens—synthetic chemicals with hormonal activities—may have unique effects on mammary tissue development, supporting the hypothesis that endocrine-disrupting chemicals could contribute to breast diseases and dysfunction through disruption of normal mammary gland development, though each compound may act through distinct mechanisms.

No results found.

You have Successfully Subscribed!

Share This